search
Back to results

Naked Eye 3D Vision Training for the Prevention and Control of Myopia in Adolescents and Children

Primary Purpose

Adolescents and Children, Axial Elongation, Naked Eye 3D Vision Training

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Naked eye 3D vision training
Sponsored by
Zhongshan Ophthalmic Center, Sun Yat-sen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Adolescents and Children

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Age 6~18 years old (including 6 years old and 18 years old), gender is not limited;
  2. Written informed consent signed by the child and legal guardian has been obtained;
  3. Patients who have visited the research center in the past month, diagnosed as myopia according to the "Guidelines for the Prevention and Treatment of Myopia" issued by the General Office of the National Health Commission (Guoweiban Medical Letter [2018] No. 393), and the spherical equivalent power is -0.75 to -6.00 Diopter (D) (including -0.75 and -6.00 D);
  4. Astigmatism≤4.00 D, anisometropia≤4.00 D;
  5. Monocular international standard logarithmic visual acuity after spectacle correction ≥20/25;
  6. The subject's guardian can understand the purpose of this study, and the subject can cooperate with the treatment and related eye examinations.

Exclusion Criteria:

  1. Any eye of the subject suffers from overt strabismus, or any other pathological changes in the eyeball or acute inflammatory disease of the eye;
  2. Subjects who may suffer from eye diseases that affect vision or refractive errors (such as cataract and other lens damage diseases, glaucoma, macular degeneration, keratopathy, uveitis, retinal detachment, severe vitreous opacity, etc.);
  3. Systemic diseases: those with a history of immune system diseases, central nervous system diseases, Down syndrome, asthma, severe heart and lung function, severe liver and kidney dysfunction;
  4. Binocular hyperopia cannot be corrected to logarithmic visual acuity of 20/25;
  5. The subject has or is undergoing myopia control treatment within the past 1 month, such as atropine eye drops, orthokeratology lenses, progressive lenses, bifocal lenses, etc.;
  6. Photophobia or unable to open eyes normally due to keratitis, trichiasis, trauma, etc. in any eye of the subjects;
  7. Subjects participated in other clinical studies 4 weeks before enrollment;
  8. For safety reasons or the interests of patients, the investigator believes that patients should not participate in other situations in this study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    intervention group

    control group

    Arm Description

    Outcomes

    Primary Outcome Measures

    the change of axial length
    mm

    Secondary Outcome Measures

    the change of vision
    Diopter
    the change of choroidal thickness
    mm
    the change of adjustment range
    Diopter
    the change of adjust sensitivity
    cycle per minute

    Full Information

    First Posted
    July 11, 2022
    Last Updated
    July 18, 2022
    Sponsor
    Zhongshan Ophthalmic Center, Sun Yat-sen University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05468775
    Brief Title
    Naked Eye 3D Vision Training for the Prevention and Control of Myopia in Adolescents and Children
    Official Title
    Naked Eye 3D Vision Training for the Prevention and Control of Myopia in Adolescents and Children
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    August 1, 2022 (Anticipated)
    Primary Completion Date
    October 1, 2022 (Anticipated)
    Study Completion Date
    October 1, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Zhongshan Ophthalmic Center, Sun Yat-sen University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The study used children aged 6-18 as subjects to evaluate the efficacy and safety of naked eye 3D vision training for the prevention and control of myopia in adolescents. A total of 250 subjects were recruited from Zhongshan Ophthalmology Center of Sun Yat-sen University, Shenzhen People's Hospital and Foshan Women's and Children's Hospital, with 1:1 as intervention group and control group. The study assumes that daily naked eye 3D vision training can effectively control the speed of axial elongation and the progression of myopia. The main indicators were the use of optical biometrics to detect the subjects' initial axial length and the axial length after 1 month, 3 months and 6 months of intervention. Secondary indicators were refraction, uncorrected visual acuity, best corrected visual acuity, choroidal thickness, and binocular vision.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Adolescents and Children, Axial Elongation, Naked Eye 3D Vision Training, Visual Function

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    250 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    intervention group
    Arm Type
    Experimental
    Arm Title
    control group
    Arm Type
    No Intervention
    Intervention Type
    Behavioral
    Intervention Name(s)
    Naked eye 3D vision training
    Intervention Description
    20 minutes of naked eye 3D vision training every day
    Primary Outcome Measure Information:
    Title
    the change of axial length
    Description
    mm
    Time Frame
    baseline, 1st months, 3rd months, 6th months
    Secondary Outcome Measure Information:
    Title
    the change of vision
    Description
    Diopter
    Time Frame
    baseline, 1st months, 3rd months, 6th months
    Title
    the change of choroidal thickness
    Description
    mm
    Time Frame
    baseline, 1st months, 3rd months, 6th months
    Title
    the change of adjustment range
    Description
    Diopter
    Time Frame
    baseline, 1st months, 3rd months, 6th months
    Title
    the change of adjust sensitivity
    Description
    cycle per minute
    Time Frame
    baseline, 1st months, 3rd months, 6th months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Years
    Maximum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Age 6~18 years old (including 6 years old and 18 years old), gender is not limited; Written informed consent signed by the child and legal guardian has been obtained; Patients who have visited the research center in the past month, diagnosed as myopia according to the "Guidelines for the Prevention and Treatment of Myopia" issued by the General Office of the National Health Commission (Guoweiban Medical Letter [2018] No. 393), and the spherical equivalent power is -0.75 to -6.00 Diopter (D) (including -0.75 and -6.00 D); Astigmatism≤4.00 D, anisometropia≤4.00 D; Monocular international standard logarithmic visual acuity after spectacle correction ≥20/25; The subject's guardian can understand the purpose of this study, and the subject can cooperate with the treatment and related eye examinations. Exclusion Criteria: Any eye of the subject suffers from overt strabismus, or any other pathological changes in the eyeball or acute inflammatory disease of the eye; Subjects who may suffer from eye diseases that affect vision or refractive errors (such as cataract and other lens damage diseases, glaucoma, macular degeneration, keratopathy, uveitis, retinal detachment, severe vitreous opacity, etc.); Systemic diseases: those with a history of immune system diseases, central nervous system diseases, Down syndrome, asthma, severe heart and lung function, severe liver and kidney dysfunction; Binocular hyperopia cannot be corrected to logarithmic visual acuity of 20/25; The subject has or is undergoing myopia control treatment within the past 1 month, such as atropine eye drops, orthokeratology lenses, progressive lenses, bifocal lenses, etc.; Photophobia or unable to open eyes normally due to keratitis, trichiasis, trauma, etc. in any eye of the subjects; Subjects participated in other clinical studies 4 weeks before enrollment; For safety reasons or the interests of patients, the investigator believes that patients should not participate in other situations in this study.

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Naked Eye 3D Vision Training for the Prevention and Control of Myopia in Adolescents and Children

    We'll reach out to this number within 24 hrs